Ptc Therapeutics (PTCT) Return on Sales (2012 - 2026)

Ptc Therapeutics' Return on Sales history runs 15 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Sales fell 1.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 1.0% decrease from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Sales rose to 0.0% in Q1 2026 per PTCT's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.02% in Q4 2024 and bottomed at 0.01% in Q4 2022.
• The 5-year median for Return on Sales is 0.01% (2023), against an average of 0.0%.
• Across the five-year window, Return on Sales gained 3 bps in 2024 and decreased 3 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.01% in 2022, then grew by 25 bps to 0.01% in 2023, then soared by 354 bps to 0.02% in 2024, then tumbled by 132 bps to 0.01% in 2025, then soared by 99 bps to 0.0% in 2026.
• Per Business Quant, the three latest PTCT Return on Sales figures stand at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.0% (Q3 2025).